UGT1A is one of the three subfamilies (UGT1A, UGT2A and UGT2B) (Hanioka et al., 2012) and was recently confirmed to promote drug resistance in some cancers (Scherer et al., 2014; Liu et al., 2015). Here, UGT1A1 is linked to cancer.